Statistics
Publications
1
Citations
45
H-Index
1
Active since
2024
Affiliations
Harvard University(Current)
Sheng Sun is an author at Harvard University specializing in recommended phase ii dose, antibody-drug conjugate therapy, and drug delivery.
Publications per year
2024–2024
1
1